WORK Medical Technology Group Consolidates Shares
Ticker: WOK · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1929783
| Field | Detail |
|---|---|
| Company | Work Medical Technology Group Ltd (WOK) |
| Form Type | 6-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $250,000, $0.0005, $10,000,000, $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-consolidation, corporate-action, foreign-issuer
TL;DR
WORK Medical Tech consolidates shares after shareholder meeting.
AI Summary
WORK Medical Technology Group LTD announced a consolidation of its ordinary shares on September 12, 2025, following an extraordinary general meeting of shareholders. The company is based in Hangzhou, China, and operates in the surgical and medical instruments sector.
Why It Matters
Share consolidation can impact a company's stock price and trading volume, potentially affecting investor perception and market liquidity.
Risk Assessment
Risk Level: low — The filing is a routine report of foreign private issuer and does not contain significant financial or operational news.
Key Players & Entities
- WORK Medical Technology Group LTD (company) — Filer of the report
- September 12, 2025 (date) — Date of extraordinary general meeting and share consolidation
FAQ
What is the purpose of the share consolidation?
The filing does not explicitly state the purpose of the share consolidation, only that it occurred on September 12, 2025, after an extraordinary general meeting of shareholders.
What is WORK Medical Technology Group LTD's primary business?
WORK Medical Technology Group LTD is involved in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, with SIC code 3841.
Where is WORK Medical Technology Group LTD located?
The company's principal executive offices are located at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, People's Republic of China.
What form is this SEC filing?
This is a Form 6-K, which is a Report of Foreign Private Issuer.
Does the company file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 925 words · 4 min read · ~3 pages · Grade level 16.1 · Accepted 2025-10-21 16:10:01
Key Financial Figures
- $250,000 — rsquo;s authorized share capital from US$250,000 divided into 400,000,000 Class A ordina
- $0.0005 — Class A ordinary shares of par value US$0.0005 each and 100,000,000 Class B ordinary s
- $10,000,000 — value US$0.0005 each, to a maximum of US$10,000,000 divided into Class A ordinary shares an
- $0.05 — Class A ordinary shares of par value US$0.05 each and 40,000,000 Class B ordinary sh
Filing Documents
- ea0261161-6k_work.htm (6-K) — 15KB
- 0001213900-25-100814.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: October 21, 2025 WORK Medical Technology Group LTD By: /s/ Shuang Wu Name: Shuang Wu Title: Chief Executive Officer 2